FDA Approved: THALOMID — Supplemental Application (Celgene Corporation)

View source ↗

Summary

FDA approved a supplemental application for THALOMID (thalidomide) submitted by Celgene Corporation, resulting in an expanded indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythema Nodosum Leprosum
• Multiple Myeloma

Drugs mentioned

• Thalomid (thalidomide)

Snippet

SUPPL AP for THALOMID (THALIDOMIDE)